你可能會喜歡
Top 10 Breast Cancer Trials to Watch at #ASCO25 Save the date ⏰ Big data in HER2+, TNBC & HR+ mBC! 1️⃣ DESTINY-Breast09 – T-DXd+P vs THP (1L HER2+ MBC) [LBA] 2️⃣ ASCENT-04 – SG+pembro vs chemo+pembro (1L TNBC) [LBA] 3️⃣ SERENA-6 – Camizestrant+CDK4/6i in ESR1mut HR+ ABC [LBA] 4️⃣…
![SuyogCancer's tweet image. Top 10 Breast Cancer Trials to Watch at #ASCO25
Save the date ⏰ Big data in HER2+, TNBC & HR+ mBC!
1️⃣ DESTINY-Breast09 – T-DXd+P vs THP (1L HER2+ MBC) [LBA]
2️⃣ ASCENT-04 – SG+pembro vs chemo+pembro (1L TNBC) [LBA]
3️⃣ SERENA-6 – Camizestrant+CDK4/6i in ESR1mut HR+ ABC [LBA]
4️⃣…](https://pbs.twimg.com/media/GrPJOdxWAAAgaeC.jpg)
Almost 1/2 of women who start endocrine therapy (ET) stop early d/t side effects. ET reduces recurrence risk in ER+, HER2- breast cancer by nearly 50%. Clinical trials assessing low dose tamoxifen (government funded) and SERDs (industry funded) are ongoing. #bcsm
Making decisions about hormonal therapy can be tricky, especially if you feel like you’re having to choose between your quality of life and lowering your risk of recurrence. These tips can help. bit.ly/4dW7aPl #hormonaltherapy #breastcancersurvivor #breastcancer
Grief is profound. But for some, there is prolonged grief disorder—a diagnosable mental health condition. Read a new Review on the condition, in The Lancet’s latest issue: hubs.li/Q03kNPxw0
Read our latest issue in full ➡️ bit.ly/42Pq2wX
I tried to create threads on X like before, but the functionality seems very limited. So, going with a long post ahead instead. ascopubs.org/doi/10.1200/OP… We have published in @JCOOP_ASCO the most comprehensive review on financial toxicity in LMICs, led by my star student…
I love this! Misinformation is the new scourge in politics and... academia.
🎉 Another research from Dr. Jesse Lopes at #SABCS24! 🎉 📚 Presented: “Factors and Trends in Place of Death Among Breast Cancer Patients: A Population-Based Study in Brazil” 🌟 Congratulations to the team for shedding light on this important topic! 🇧🇷👏 #BreastCancer…
🇧🇷Dr. Jesse Lopes, from INCA, and Coauthors at #SABCS24! 🎉 📚 Presented: “Age at Breast Cancer Diagnosis and Associated Demographic Factors: An Epidemiological Study in Brazil” 🌟 Congratulations to the team for their work! 🇧🇷👏 #BreastCancerResearch #Epidemiology 🩺✨…
Natália Nunes, from Rio de Janeiro, and her co-authors presented their impactful data at #SABCS24: “Patient-Reported Outcomes in Premenopausal Breast Cancer Patients With or Without Ovarian Suppression Therapy: A Subgroup Analysis From a Brazilian Prospective Cohort.” 🎗️🇧🇷✨…
#SABCS24 is underway! Christine Ambrosone, Heather Greenlee, @drdonsdizon, Rikki Cannioto, Lawrence Kushi, and Tomika Bryant discuss supplements and cannabis, sexual health, exercise during treatment, and the impact of alcohol use during a session on "Sex, Drugs, Rock & Roll."
ESMO encourages @roxana_minzatu to support a ‘Burnout’ Directive on work-related psychosocial risks at the @Europarl_EN Commissioners-designate hearings. #wellbeing #MentalHealth #ESMO4Carers #ESMOManifesto 👉 esmo.org/policy/esmo-ma…
📝Dosing of selected anticancer agents in hepatic dysfunction 👇 @ASCO @OncoAlert #cancer #oncology #MedX
Já leram meu fio sobre cotas?
Um fio explicando pq cotas devem ser primariamente raciais, usando tb critérios de renda, mas secundariamente. Explico, usando, como sempre, artigos científicos para embasar a explicação. O resultado é simples: cotas raciais > cotas para pobres. Segue o fio: (1/n)
On this day in 2005, the HERA study on breast cancer was published in NEJM. In the past 20 years, nearly 3 million women have been treated with trastuzumab, the first approved fully humanized monoclonal antibody. nej.md/48gSAA7 #pinktober #BreastCancerAwareness
Hoje começamos nosso Simpósio Internacional Oncologia Americas!
🎙️ O Instituto Americas lança seu novo podcast "Raízes" e o primeiro episódio com a Dra. Natalia Nunes, Oncologista Clínica e Pesquisadora do Instituto Americas e o psicólogo Shai Bittencourt (CRP: 05/55872) já está disponível no Spotify: open.spotify.com/episode/5oJV1g…
United States 趨勢
- 1. Branch 35.3K posts
- 2. Chiefs 110K posts
- 3. Red Cross 46.2K posts
- 4. Mahomes 34.2K posts
- 5. #LaGranjaVIP 78.9K posts
- 6. Binance DEX 5,084 posts
- 7. #TNABoundForGlory 58K posts
- 8. Rod Wave 1,512 posts
- 9. #LoveCabin 1,292 posts
- 10. Air Force One 50.1K posts
- 11. Bryce Miller 4,558 posts
- 12. Eitan Mor 12.6K posts
- 13. Alon Ohel 12.7K posts
- 14. #OnePride 6,447 posts
- 15. LaPorta 11.5K posts
- 16. Tel Aviv 53.9K posts
- 17. Dan Campbell 4,011 posts
- 18. Kelce 16.8K posts
- 19. Goff 13.8K posts
- 20. Omri Miran 12.9K posts
你可能會喜歡
-
Edoardo Crimini MD
@CriminiMd -
Maria Lucia Reale
@marialuciareale -
Hiroaki Kanemura
@hirokane05 -
Jp Solar Vasconcelos
@jaypsv -
Paolo Tarantino
@PTarantinoMD -
Rafael H. Santos Abduch
@rafaelabduch -
Birute Brasiuniene MD PhD
@brasiuniene -
Maryam Lustberg MD, MPH, FASCO
@maryam_lustberg -
KIJJAKOM THANASOMBUNSUKH
@KijjakomT -
Daniel Sur
@DanielSur10 -
Francesca Poggio
@Poggio_Fra -
Juliana Beal, MD
@JulianaRBeal -
Pedro Guimarães
@pehengui
Something went wrong.
Something went wrong.